journal
MENU ▼
Read by QxMD icon Read
search

Health Economics, Policy, and Law

journal
https://www.readbyqxmd.com/read/28443522/legal-and-organisational-innovation-in-the-italian-pharmacy-system-commercial-vs-public-interest
#1
Alceste Santuari
Pharmacy services are undoubtedly an important part of primary care. Pharmacists are entrepreneurs and simultaneously they are entrusted with a public mission in the health care sector. Pharmacies then reflect a contrast between a commercial/economic objective and public interest, which is to be identified with citizens' universal right to health care services. This is the reason why in Italy, as in many other EU countries, pharmacies supply their services according to a prior authorisation granted by public authorities...
April 26, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28416025/healthcare-innovation-and-patent-law-s-pharmaceutical-privilege-is-there-a-pharmaceutical-privilege-and-if-so-should-we-remove-it
#2
Graham Dutfield
This article reviews current trends in patent claims regarding personalised, stratified and precision medicine. These trends are not particularly well understood by policymakers, even less by the public, and are quite recent. Consequently, their implications for the public interest have hardly been thought out. Some see personalised and other secondary drug patent claims as promoting better targeted treatment. Others are inclined to see them as \manifestations of 'evergreening' whereby companies are, in some cases quite cynically, trying to extend market monopolies in old products or creating new monopolies based on supposedly improved versions of such earlier drugs...
April 18, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28414005/health-care-and-health-innovation-in-europe-regulating-for-public-benefit-or-for-commercial-profit
#3
Amanda Warren-Jones
No abstract text is available yet for this article.
April 17, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28414003/regulatory-theory-commercially-sustainable-markets-rely-upon-satisfying-the-public-interest-in-obtaining-credible-goods
#4
Amanda Warren-Jones
Regulatory theory is premised on the failure of markets, prompting a focus on regulators and industry from economic perspectives. This article argues that overlooking the public interest in the sustainability of commercial markets risks markets failing completely. This point is exemplified through health care markets - meeting an essential need - and focuses upon innovative medicines as the most desired products in that market. If this seemingly invulnerable market risks failure, there is a pressing need to consider the public interest in sustainable markets within regulatory literature and practice...
April 17, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28382886/outsourcing-day-surgery-to-private-for-profit-hospitals-the-price-effects-of-competitive-tendering
#5
Terje P Hagen, Geir Hiller Holom, Kebebew N Amayu
Setting prices for elective patient treatments in private for-profit (PFP) hospitals in traditional tax-funded health systems is challenging since both the organisation of these hospitals and the tasks they perform differ considerably from what we find in public hospitals. From the year 2000, Norway became one of a few countries to gradually implement a procurement system based on competitive tendering when outsourcing elective surgery. In this study we analyse the effect of introducing competitive tendering on the prices paid to PFP hospitals...
April 6, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28345498/the-effects-of-payments-for-pharmaceuticals-a-systematic-literature-review
#6
Katarzyna Kolasa, Marta Kowalczyk
The existence of different forms of out-of-pocket payments (OOPs) for pharmaceuticals across the globe provokes the question whether they can achieve more negative or positive consequences. A systematic literature review was conducted to assess the association between drug cost sharing and health care services utilization, health care costs as well as health outcomes. Studies published in The Cochrane Library, PubMed, Embase were searched with such keywords as: drug, pharmaceutical, cost sharing, out of pocket, co-payments paired with the following: impact, health outcomes, health care costs and utilization...
March 27, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28322184/the-norwegian-national-council-for-priority-setting-in-health-care-decisions-and-justifications
#7
Gry Wester, Berit Bringedal
Different countries have adopted different strategies for tackling the challenge of allocating scarce health care resources fairly. Norway is one of the countries that has pioneered the effort to resolve priority setting by using a core set of priority-setting criteria. While the criteria themselves have been subject to extensive debate and numerous revisions, the question of how the criteria have been applied in practice has received less attention. In this paper, we examine how the criteria feature in the decisions and justifications of the Norwegian National Council for Priority Setting in Health Care, which has played an active role in deliberating about health care provision and coverage in Norway...
March 21, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28294093/identifying-health-system-value-dimensions-more-than-health-gain
#8
Joan Costa-Font, Azusa Sato, Joan Rovira Forns
Publicly funded health system reforms increasingly require the evaluation of competing programmes. However, programmes are made of multi-dimensional attributes of value (where value refers to latent expectations of health system improvement). This paper identifies the design, implementation and validation of a methodology to elicit health system values to guide health care priority setting. The exercise suggests that the proposed methodology is suitable for eliciting and validating health system values, and its findings show that pursuing health gain alone does not fully capture the dimensions of health system value...
March 15, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28290918/health-plan-choice-in-the-netherlands-restrictive-health-plans-preferred-by-young-and-healthy-individuals
#9
Romy E Bes, Emile C Curfs, Peter P Groenewegen, Judith D de Jong
In a health care system based on managed competition, health insurers negotiate on quality and price with care providers and are allowed to offer restrictive health plans. It is crucial that enrolees who need care choose restrictive health plans, as otherwise health insurers cannot channel patients to contracted providers and they will lose their bargaining power in negotiations with providers. We aim to explain enrolees' choice of a restrictive health plan in exchange for a lower premium. In 2014 an online survey with an experimental design was conducted on members of an access panel (response 78%; n=3,417)...
March 14, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28249636/adopting-new-medical-technologies-in-russian-hospitals-what-causes-inefficiency-qualitative-study
#10
Sergey Shishkin, Liudmila Zasimova
The adoption of new medical technologies often generates losses in efficiency associated with the excess or insufficient acquisition of new equipment, an inappropriate choice (in terms of economic and clinical parameters) of medical equipment, and its poor use. Russia is a good example for exploring the problem of the ineffective adoption of new medical technologies due to the massive public investment in new equipment for medical institutions in 2006-2013. This study examines the procurement of new technologies in Russian hospitals to find the main causes of inefficiency...
March 2, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28228176/the-state-of-american-health-care-november-2016-to-november-2020-a-look-forward
#11
Theodore Marmor, Michael K Gusmano
The election of Donald Trump, coupled with the retention of Republican majorities in the US House of Representatives and Senate, raises questions about future of the Patient Protection and Affordable Care Act, the structure and funding of the country's public health insurance programs - Medicare, Medicaid and the Child Health Insurance Program - and the direction of health policy in the United States, more generally. Political scientists are not renowned for their capacity to predict the future and many of those who forecast election results have received criticism in recent weeks for failing to predict the Trump victory...
February 23, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332466/towards-a-coherent-global-framework-for-health-financing-recommendations-and-recent-developments
#12
Trygve Ottersen, Riku Elovainio, David B Evans, David McCoy, Di Mcintyre, Filip Meheus, Suerie Moon, Gorik Ooms, John-Arne Røttingen
The articles in this special issue have demonstrated how unprecedented transitions have come with both challenges and opportunities for health financing. Against the background of these challenges and opportunities, the Working Group on Health Financing at the Chatham House Centre on Global Health Security laid out, in 2014, a set of policy responses encapsulated in 20 recommendations for how to make progress towards a coherent global framework for health financing. These recommendations pertain to domestic financing of national health systems, global public goods for health, external financing for national health systems and the cross-cutting issues of accountability and agreement on a new global framework...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332465/the-challenge-of-middle-income-countries-to-development-assistance-for-health-recipients-funders-both-or-neither
#13
Trygve Ottersen, Suerie Moon, John-Arne Røttingen
Recent developments have transformed the role and characteristics of middle-income countries (MICs). Many stakeholders now question the appropriate role of MICs in the system of development assistance for health (DAH), and key funders have already recast their approach to these countries. The pressing question is whether MICs should be recipients, funders, both or neither. The answer has deep implications for individual countries and their citizens, and for the DAH system as a whole. We clarify the fundamental issues involved and emphasise a special feature of many MICs: mid-level gross national income per capita (GNIpc) combined with substantial health needs and large inequalities...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332464/distributing-development-assistance-for-health-simulating-the-implications-of-11-criteria
#14
Trygve Ottersen, Suerie Moon, John-Arne Røttingen
After years of unprecedented growth in development assistance for health (DAH), the DAH system is challenged on several fronts: by the economic downturn and stagnation of DAH, by the epidemiological transition and increase in non-communicable diseases and by the economic transition and rise of the middle-income countries. Central to any potent response is a fair and effective allocation of DAH across countries. A myriad of criteria has been proposed or is currently used, but there have been no comprehensive assessment of their distributional implications...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332463/development-assistance-for-health-critiques-proposals-and-prospects-for-change
#15
Suerie Moon, Oluwatosin Omole
After a 'golden age' of extraordinary growth in the level of development assistance for health (DAH) since 1990, funding seems to have reached a plateau. With the launch of the Sustainable Development Goals, debate has intensified regarding what international financing for health should look like in the post-2015 era. In this review paper, we offer a systematic overview of problems and proposals for change. Major critiques of the current DAH system include: that the total volume of financing is inadequate; financial flows are volatile and uncertain; DAH may not result in additional resources for health; too small a proportion of DAH is transferred to recipient countries; inappropriate priority setting; inadequate coordination; weak mechanisms for accountability; and disagreement on the rationale for DAH...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332462/development-assistance-for-health-what-criteria-do-multi-and-bilateral-funders-use
#16
Trygve Ottersen, Aparna Kamath, Suerie Moon, Lene Martinsen, John-Arne Røttingen
After years of unprecedented growth in development assistance for health (DAH), the system is challenged on several fronts: by the economic downturn and stagnation of DAH, by the epidemiological transition and increase in non-communicable diseases, and by the economic transition and rise of the middle-income countries. This raises questions about which countries should receive DAH and how much, and, fundamentally, what criteria that promote fair and effective allocation. Yet, no broad comparative assessment exists of the criteria used today...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332461/global-public-goods-for-health-weaknesses-and-opportunities-in-the-global-health-system
#17
Suerie Moon, John-Arne Røttingen, Julio Frenk
Since at least the 1990s, there has been growing recognition that societies need global public goods (GPGs) in order to protect and promote public health. While the term GPG is sometimes used loosely to denote that which is 'good' for the global public, we restrict our use of the term to its technical definition (goods that are non-excludable and non-rival in consumption) for its useful analytical clarity. Examples of important GPGs for health include standards and guidelines, research on the causes and treatment of disease, and comparative evidence and analysis...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332460/framing-the-tax-and-health-nexus-a-neglected-aspect-of-public-health-concern
#18
David Mccoy, Simukai Chigudu, Taavi Tillmann
Previous studies have described various associations between tax policy and health. Here we propose a unifying conceptual framework of 'Five R's' to stimulate awareness about the importance of tax to health improvement. First, tax can improve representation and democratic accountability, and help make governments more responsive to the needs of its citizens. Second, tax can create a revenue stream for a universal pool of public finance for health care and other public services. Third, progressive taxation when combined with appropriate public spending can help redistribute wealth and income and mitigate social and health inequalities...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332459/fiscal-space-for-domestic-funding-of-health-and-other-social-services
#19
Filip Meheus, Di McIntyre
To progress toward universal health coverage and promote inclusive social and economic development, it will be necessary to strengthen domestic resource mobilization for health. In this paper, we examine options for increasing domestic government revenue in low- and middle-income countries. We analyze the relationship between level of economic development and levels of government revenue and expenditure, and show that a country's level of economic development does not predetermine its spending levels. Government revenue can be increased through improved tax compliance and efficiency in revenue collection, maximizing revenue from mineral and other natural resources, and increasing tax rates where appropriate...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332458/raising-more-domestic-money-for-health-prospects-for-low-and-middle-income-countries
#20
Riku Elovainio, David B Evans
Since the 2007/2008 financial crisis, the rhetoric in the development assistance dialogue has shifted away from raising more international funding for health, to requesting countries to move toward self-sufficiency. This paper examines the potential of 46 countries identified by an international panel in 2009 as being of high need to raise additional funding for health from domestic sources. Economic growth alone would allow 12 of them to reach a level of health spending where their populations could have access to a very basic set of health services...
April 2017: Health Economics, Policy, and Law
journal
journal
41056
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"